Vaginal Microbiome of Women with Premature Ovarian Insufficiency: a Descriptive Cross-sectional Study

Objective: This study aimed to describe the vaginal microbiome of women with premature ovarian insufficiency (POI) receiving systemic hormone therapy (HT).

Methods: Forty women with POI receiving systemic HT for at least 6 months, who were sexually active, were included in the descriptive cross-sectional study. Vaginal secretion was collected for DNA extraction followed by pyrosequencing of the 16S rRNA. The samples were pooled into phylogenetic groups (Ravel groups I-V).

Results: Women had mean age of 37.13 (± 7.27) years and POI diagnosis at age 27.90 (± 8.68) years, and a mean HT duration of 8.20 (± 8.73) years. It was observed that 33.4% of the women presented group I flora, with a predominance of ; 9% group II flora, with a predominance of ; 33.4% group III flora, with a predominance of ; 15.2% group IV flora, with a predominance of anaerobic bacteria; and 9% group V flora, with a predominance of .

Conclusion: Women with POI receiving HT presented a vaginal microbiome with a predominance of lactobacilli in the composition of the vaginal flora, specifically and when evaluated by molecular biology through pyrosequencing of 16S rRNA.